Vigil Neuroscience, Inc. (VIGL)
NASDAQ: VIGL · IEX Real-Time Price · USD
4.010
+0.290 (7.80%)
Jul 22, 2024, 10:13 AM EDT - Market open
Vigil Neuroscience Employees
Vigil Neuroscience had 69 employees as of December 31, 2023. The number of employees increased by 13 or 23.21% compared to the previous year.
Employees
69
Change (1Y)
13
Growth (1Y)
23.21%
Revenue / Employee
n/a
Profits / Employee
-$1,199,754
Market Cap
140.57M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 69 | 13 | 23.21% |
| Dec 31, 2022 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Amylyx Pharmaceuticals | 384 |
| Cellectis | 221 |
| EUDA Health Holdings | 106 |
| Invivyd | 95 |
| Elevation Oncology | 29 |
| Corvus Pharmaceuticals | 28 |
| PDS Biotechnology | 25 |
| Citius Pharmaceuticals | 22 |
VIGL News
- 3 days ago - Vigil Announces Upcoming Presentations on its Small Molecule TREM2 Agonist VG-3927 at the 2024 Alzheimer's Association International Conference - GlobeNewsWire
- 4 days ago - Vigil Neuroscience Provides Update on Clinical Development Strategy to Pursue Potential Accelerated Approval Pathway for Iluzanebart in ALSP - GlobeNewsWire
- 14 days ago - SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Vigil Neuroscience, Inc. (NASDAQ: VIGL) - PRNewsWire
- 25 days ago - Vigil Neuroscience Announces $40 Million Strategic Investment from Sanofi - GlobeNewsWire
- 26 days ago - Augustine Therapeutics Raises EUR 17 Million in a Series A First Closing to Advance Lead Candidate Into Clinical Development in Neurological Diseases - Business Wire
- 7 weeks ago - Vigil Neuroscience to Present in Upcoming June Investor Conferences - GlobeNewsWire
- 2 months ago - Vigil Neuroscience to Present at The Citizens JMP Life Sciences Conference - GlobeNewsWire
- 2 months ago - Vigil Neuroscience Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire